Hydrocodone Case Studies

1000 Pt denied pain at this time and rate 0 on a scale of 0 to 10. Pt thanks me a lot for pain medication I gave her. Instruct the pt to report her pain early before it get worse so I can give pain medication. Pt verbalized understanding of the teaching. No sign of distress or discomfort at this time. Will continue to monitor………L.Gotora

Williams, the patient reports occasional low back pain that he rates from 0-3/10. On this visit, he has no low back pain.

The patient states that she continues to have pain, every single day. Her shoulder pain has started to radiate up to her neck. Shoulder pain is rated to a 9/10 without medications, and 5/10 with medication.

At today's visit, she is accompanied by her husband. She is awake, alert and oriented. She complains of chronic, dull, intermittent, burning pain in her thighs which radiates down her legs. She rates her pain as a 3/10. She states that taking the

Per medical report dated 03/17/16, patient’s medications are chlordiazepoxide 10 mg, Butrans 10 mcg, Fentanyl 75 mcg, Norco 10 mg/325 mg, venlafaxine ER 75 mg, Ambien CR 12.5 mg, Cymbalta 60 mg, Capsaicin Hot Patches 0.025% Ext Pads, terazosin, Levothyroid 125 mcg and Androgel pump 1%.

12/24/15 Progress Report describes that the patient has right knee pain. The pain is frequent. It is aching and burning in quality. The current pain level is 0/10 and worst pain is 4/10. Bending, squatting, walking, weight bearing, changing clothes and ROM aggravate the pain. Rest, ice,

At today’s visit she is found sitting in the chair, she is awake, alert, and confused. I am asked to seek this pain for new onset pain. The patient complains of acute pain in pubic area and right hip area, pain is dull, achy, severity 4/10, pain is worse with walking. At this time the patient is not taking anything for pain. The ALF staff reports that the patient has daily anxiety and has to be given Ativan three times daily. The patient ambulates with a walker. Gait is

Based on the progress report dated 09/12/16, the patient reports more frequent pain with activity since the last

On Primary Treating Physician’s Progress Report (PR-2) dated 08/11/2017, the patient presented with unchanged symptoms. His left-hand pain was rated at 8/10. and was described as constant and sharp. The pain was aggravated with certain movements and gripping. The

Citalopram HBR 20mg (1x daily), Clonazipam 2mg (1x daily), albuterol (as needed), Ventolin (as needed), ondonsetronorally disintegrating tablet 8mg (as needed), ibuprofen 800mg ( as needed), Benadryl 25mg ( as needed) fluticasone propronate 50mg 1 daily.

) Discuss the public health impact of opioid misuse and abuse, including costs related to healthcare and criminal justice costs. Opioid drugs are valuable medications in treating acute and chronic pain that cannot be managed with nonopioid therapy, but inappropriate prescribing can cause serious harm. Taking higher doses or a combination of short-acting and long-acting opioids are likely to be abused and can also cause serious dose-related adverse effects that can include death. Opioid abuse affects the community and families in some way. It can lead missed work and sometimes it can be a problem keeping a job. Therefore, it is important that we obtain medication history to give us a picture of the patient pain medication history. While opioid

Per the Agreed Medical Re-Examination report dated 09/29/15, whole person impairment rating is 5%. Future medical care includes access to follow-up visits for monitoring of his condition for the next calendar year, with continued provision of pharmacological agents. Should patient experience a significant acute symptoms flare-up within the next calendar year, re-instatement of brief courses of traditional PT, acupuncture,

While narcotics are most commonly used to treat acute pain, opioids, one subgroup of narcotics, are being used most commonly to treat chronic pain. The number of opioid prescriptions has been on the rise over the past 25 years, increasing from “76 million prescriptions in 1991 to nearly 207 million in 2013” (Volkow, 2014, p. 1). This has no doubt contributed to the increasing number of unintentional overdose deaths seen in recent years. The United States has seen their unintentional overdose rates quadruple since 1999, which may be explained by the fact that the United States is responsible for the use of nearly all of the word’s hydrocodone (Volkow, 2014).

Many addictions to these opiates are caused by inaccurate treatment of pain by the patient’s doctors. According to Andrea M. Garcia, “Treatment of pain is inadequate due to uncertain diagnoses, societal stigma, the lack of effective treatments, and inadequate patient and clinician knowledge about the best ways to manage pain. Prescription painkiller overdose has reached epidemic proportions over the past decade.” When patients visit a doctor’s office due to pain, they often do not elaborate on the pain they feel or give accurate diagnosis of the pain they are experiencing. Patients will often over exaggerate their pain level in order to be prescribed higher doses of narcotics. Shoulder or knee pain is a very common complaint. Patients who

Hydrocodone a drug used to change how your brain and your nervous system reacts to pain. When taken the medication correctly it should relieve mood, reduction of pain. Hydrocodone was introduced in the 1920’s from the country of Germany. Carl Mannich and Helenen Lowenheim were the first to report it being in use in 1923( Eckenrode, S. L. (2015).Hydrocodone is a form of opiate, analgesic, it is described as white crystals as a crystalline powder and reacts to light. This drug classified as a schedule II drug known as a controlled substance. Hydrocodone is often always found in combination with acetaminophen such as Vicodin and Lortab (Advokat, C. D., Comaty, J. E., & Julien, R. M. 2014). As of 2012, the United States Hydrocodone is the most used drug prescribed to treat pain. The United States has consumed 99% of this global supply for 4.4% of the worldwide population. (Manchikanti, L., Atluri, S., Kaye, A.M., Kaye, A.D). The US Drug and food administration approved the drug for sale in the United States in 1943.